Pharmaceutical industry-regulator relations

What’s the issue? Communications teams at pharma firms and within pharma trade associations have their work cut out to counter challenges to the reputation of the industry. The Guardian reported on Monday that Pfizer received advice in 1989 from an expert on the Committee on the Safety of Medicines about the way to gain approval for its anti-depressant drug sertraline (branded as Lustral).